vitamin k 3 has been researched along with Leukemia, T-Cell in 1 studies
Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.
Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, W | 1 |
| Wu, H | 1 |
| Chen, S | 1 |
| Wang, X | 1 |
| Tanaka, S | 1 |
| Sugiyama, K | 1 |
| Yamada, H | 1 |
| Hirano, T | 1 |
1 other study available for vitamin k 3 and Leukemia, T-Cell
| Article | Year |
|---|---|
Cytotoxic effects of vitamins K1, K2, and K3 against human T lymphoblastoid leukemia cells through apoptosis induction and cell cycle arrest.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Humans; Leukemia, T-Cell; Vitamin K 1; Vitamin K 2; Vitamin | 2020 |